Home› Procurement News - Gilead and merck announce positive topline results from two phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly hiv treatment, United states (533820469)

Public procurement notice for Gilead and merck announce positive topline results from two phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly hiv treatment has been released by in United states. Bid submissions are open until 09 Jun 2026.

Procurement News

Procurement News
News TI Ref No
533820469
News Date
09 Jun 2026
News Description
Gilead and merck announce positive topline results from two phase 3 studies evaluating islatravir/lenacapavir, an oral once-weekly hiv treatment
Tender Deadline
⏰ 09 Jun 2026 Closing soon
News Project Location
United States
News Sector
Healthcare and Medical Tenders
News Document Type
Procurement News
Tender Organization Name
🔒 Members only Click for more details
Unlock Full Details — Register Free
Start with receiving Free Data Samples related to your Products and Services
✓
Live Tender Updates from worldwide
✓
Access to original Tender Documents
✓
Information on Upcoming Projects & Contract Awards
✓
Bid Assistance Services
✓
Competitor Analysis & Industry Trends
✓
Daily Custom Email Alerts by Sector & Country

Similar News

View All Healthcare and Medical Tenders Tenders ->

Register to View Tenders

Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.

Already have an account? Login here

By registering you agree to our Terms & Conditions and Privacy Policy.